Skip to main content
SpringerLink
Log in

The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus

  • Original Papers
  • Published:
Archives of Virology Aims and scope Submit manuscript

Summary

Comparative studies on the local IgA, and circulating IgG subclass antibody responses of mice to A/Sichuan/2/87 (H3N2) influenza virus surface antigens administered with different carrier or delivery systems by the parenteral route, were carried out. The results obtained were compared with the responses observed following live influenza virus infection, and the protection afforded to these animals by these various preparations determined.

Infection with live virus elicited early and high levels of protection against homologous virus challenge and this correlated with both local IgA and circulating IgG2a antibody levels. When incorporated into immunostimulating complexes (ISCOMS), A/Sichuan surface antigens promoted high levels of local IgA and circulating IgG1 antibody, and achieved a more rapid and more solid immunity against homologous virus challenge infection, than that elicited by the same surface antigens administered alone or together with Freund's complete adjuvant or alhydrogel.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Al-Khayatt R, Jennings R, Potter CW (1984) Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg 92: 301–312

    Google Scholar 

  2. Balkovic ES, Florack JA, Six HR (1987) Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different forms. Antiviral Res 8: 151–160

    Google Scholar 

  3. Bomford R (1990) Immunomodulation by adjuvants. In: Dimmock NJ, Griffiths PD, Madeley CR (eds) Control of infectious diseases. Cambridge University Press, Cambridge, pp 143–154

    Google Scholar 

  4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Anal Biochem 72: 284–254

    Google Scholar 

  5. Clements ML, Betts RF, Murphy BR (1984) Advantage of live, attenuated, cold-adapted influenza A virus over inactivated vaccines for A/Washington/80 (H3N2) wildtype virus infection. Lancet i: 705–708

    Google Scholar 

  6. Clements ML, Murphy BR (1986) Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A vaccine. J Clin Microbiol 23: 66–72

    Google Scholar 

  7. Coutelier J-P, Van der Logt JPM, Heesen FWA, Warnier G, Van Snick J (1987) IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 165: 64–69

    Google Scholar 

  8. Crawford CR, Mukhlis FA, Jennings R, Oxford JS, Hockley DJ, Potter CW (1984) Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1. Preparation and characterisation of disrupted virions. Vaccine 2: 193–198

    Google Scholar 

  9. De Vries P, Van Binnendijk RS, Van der Marel P, Van Wezél AL, Voorma HO, Sundquist B, Uytdehaag FGCM, Osterhaus ADME (1988) Measles virus fusion protein presented in an immune-stimulating complex (ISCOM) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol 69: 549–559

    Google Scholar 

  10. Hocart MJ, Mackenzie JS, Stewart GA (1988) The IgG subclass responses induced by wild-type, cold-adapted and purified haemagglutinin from influenza virus A/Queensland/6/72 in CBA/CaH mice. J Gen Virol 69: 1873–1882

    Google Scholar 

  11. Hoglund S, Dalsgaard K, Lovgren K, Sundquist B, Osterhaus ADME, Morein B (1989) ISCOMS and immunostimulation with viral antigens. In: Harris JR (ed) Subcellular biochemistry, vol 15. Plenum, New York, pp 39–68

    Google Scholar 

  12. Jennings R, Denton MD, Potter CW (1976) The hamster as an experimental animal for the study of influenza. I. The role of antibody in protection. Med Microbiol Immunol 162: 217–226

    Google Scholar 

  13. Jennings R, Potter CW, Massey PMO, Duerden BI, Martin J, Bevan AM (1981) Response of volunteers to inactivated influenza virus vaccines. J Hyg 86: 1–16

    Google Scholar 

  14. Jennings R, Quasim T, Sharrard RM, Hockley D, Potter CW (1988) Zwitterionic detergent solubilisation of HSV-1 specific surface antigens. Arch Virol 98: 137–153

    Google Scholar 

  15. Jennings R, Smith T, Potter CW (1981) Use of enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study. Med Microbiol Immunol 169: 247–258

    Google Scholar 

  16. Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF (1986) Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine and inactivated vaccine. J Infect Dis 154: 121–127

    Google Scholar 

  17. Liew FY, Russell SM, Appleyard G, Brand CM, Beale J (1984) Cross protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cells reactivity. Eur J Immunol 14: 350–356

    Google Scholar 

  18. Lovgren K (1988) The serum antibody response distributed in subclass and isotypes after intranasal and subcutaneous immunisation with influenza virus immunostimulating complexes. Scand J Immunol 27: 241–245

    Google Scholar 

  19. Lovgren K, Kaberg H, Morein B (1990) An experimental influenza subunit vaccine (ISCOM): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration. Clin Exp Immunol 82: 435–439

    Google Scholar 

  20. McLaren C, Grubbs GE, Staton E, Barthlow W, Quinnan G, Ennis FA (1980) Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice. Infect Immun 28: 171–177

    Google Scholar 

  21. Morein B, Sundquist B, Hoglund S, Dalsgaard K, Osterhaus A (1984) Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308: 457–460

    Google Scholar 

  22. Murphy BR, Clements ML (1989) The systemic and mucosal immune response of humans to influenza A virus. Curr Top Microbiol Immunol 146: 107–116

    Google Scholar 

  23. Potter CW, Jennings R, McLaren C (1973) Immunity to influenza virus in ferrets. VI. Immunisation with adjuvanted vaccines. Arch Ges Virusforsch 42: 285–290

    Google Scholar 

  24. Potter CW, Oxford JS (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35: 69–75

    Google Scholar 

  25. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27: 493–497

    Google Scholar 

  26. Renegar KB, Small PA Jr (1991) Immunoglobulin A mediation of murine nasal antiinfluenza virus immunity. J Virol 65: 2146–2148

    Google Scholar 

  27. Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH (1988) Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults. J Infect Dis 158: 1209–1219

    Google Scholar 

  28. Sundquist B, Lovgren K, Morein B (1988) Influenza virus ISCOMS: antibody responses in animals. Vaccine 6: 49–53

    Google Scholar 

  29. Tao S-J, Yang D-R, Guo D (1987) Treatment of experimental influenza viral infection with monoclonal antibody against H3N2 influenza virus. Virus Inform Exchange Newslett 4: 15

    Google Scholar 

  30. Wagner DK, Clements ML, Reimer CB, Snyder M, Nelson DL, Murphy BR (1987) Analysis of immunoglobulin G responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J Clin Microbiol 25: 559–562

    Google Scholar 

  31. Webster RG, Askonas BA (1980) Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol 10: 396–401

    Google Scholar 

  32. Wood JM, Schild GC, Newman RW, Seagroatt V (1977) Application of an improved single-radial immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines. Dev Biol Stand 39: 139–200

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental and Clinical Microbiology, University of Sheffield Medical School, Sheffield, UK

    E. T. S. Ben Ahmeida, R. Jennings, M. Erturk & C. W. Potter

Authors
  1. E. T. S. Ben Ahmeida
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Jennings
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Erturk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. W. Potter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ben Ahmeida, E.T.S., Jennings, R., Erturk, M. et al. The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus. Archives of Virology 125, 71–86 (1992). https://doi.org/10.1007/BF01309629

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01309629

Keywords

Search

Navigation